Cloud-native eQMS platform with AI-powered workflows, document management, CAPA, training, EBR, and inspection management for regulated industries.
ACE (Adaptive Compliance Engine) is a cloud-native enterprise quality management system (eQMS) serving 1,000+ clients across 100+ countries. The platform unifies document lifecycle management, CAPA, training (ACE LMS), electronic batch records (ACE EBR), inspection management (ACE Inspection), analytics, and AI-powered workflows (ACE Intelligence) on a single system.
Designed for regulated industries from startups to global enterprises, ACE features automated audit trails, role-based access controls, and real-time analytics. The platform meets FDA 21 CFR Part 11 and EU Annex 11 compliance standards with electronic signatures, complete audit trails, and data integrity controls.
Notable customers include Pfizer, Novartis, Lonza, Samsung Biologics, AstraZeneca, and Mark Cuban Cost Plus Drug Company. Implementation options range from ACE Essentials (pre-configured startup solution) to full enterprise deployments with validation support, data migration, and system administration services.
ACE serves biotech/pharma, medical devices, CDMO/CMO manufacturers, food & beverage, and dietary supplements. The platform emphasizes inspection readiness with AI-powered regulatory insights and audit management capabilities.
ACE Essentials is a ready-to-go compliance suite designed for pharma startups and small biotech companies, with pre-configured workflows for document management, training, deviation investigations, CAPA, and reporting. Mark Cuban Cost Plus Drug Company adopted ACE Essentials for FDA compliance from day one. Platform includes specialized support for GMP, FDA 21 CFR Part 11, EU Annex 11, and electronic batch records for pharma manufacturing.
ACE is delivered as a cloud-native SaaS platform, emphasizing modern cloud architecture for scalability and accessibility. The system is accessible via web browsers without requiring VPN connections, enabling global access for the 1,000+ clients across 100+ countries. The platform supports role-based access controls to manage user permissions and data security across distributed teams.
ACE offers integration capabilities through APIs for connecting with ERP systems, laboratory instruments, and other enterprise systems. The platform includes real-time analytics dashboards and reporting tools that aggregate data from multiple ACE modules (Docs, LMS, CAPA, EBR, etc.) into unified views. The cloud-native architecture supports automated updates and scalability to accommodate organizations ranging from startups to large enterprises with 2,000+ employees. Specific cloud provider details (AWS, Azure, GCP) are not publicly disclosed, but the multi-tenant cloud infrastructure supports global deployment and data residency requirements for international clients.
PSC ACE operates on a subscription-based SaaS pricing model with pricing not publicly disclosed. The company offers ACE Essentials as a pre-configured entry-level solution marketed to startups and small pharmaceutical companies, indicating tiered pricing aligned with organizational size and module requirements.
Pricing structure is based on factors including number of users, modules selected (Docs, LMS, CAPA, EBR, etc.), organization size, and implementation services required. The platform serves organizations ranging from startups to large enterprises (Pfizer, Novartis, AstraZeneca), indicating flexible pricing across multiple market segments. Free trial availability is not publicly advertised.
PSC Software provides comprehensive implementation services including validation support, data migration, and system administration training. For startups and small companies, ACE Essentials offers a pre-configured solution designed for rapid deployment with ready-to-go compliance workflows for document management, training, deviations, CAPA, and reporting. Mark Cuban Cost Plus Drug Company implemented ACE Essentials for FDA compliance from day one.
For larger enterprises, PSC offers full-service implementation with customization capabilities, legacy system data migration, and comprehensive validation documentation packages. The platform supports data import from Excel/CSV and legacy QMS systems through API-based migration tools. Implementation services include workflow configuration, user training, validation protocol execution, and go-live support. The company's 25+ years of experience and 300+ employee workforce enables dedicated implementation teams for complex enterprise deployments. Specific implementation timelines are not publicly disclosed but vary based on organizational size, scope of modules deployed, and customization requirements.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
No third-party review platform lists this product, so nothing below is aggregated from users; each item is drawn from vendor materials and the named customer base. Module coverage spans ACE Docs, ACE LMS, ACE CAPA and ACE EBR, with AI-powered workflows through ACE Intelligence and stated FDA 21 CFR Part 11 and EU Annex 11 compliance. Named customers include Pfizer, Novartis, AstraZeneca, Lonza and Samsung Biologics. ACE Essentials is marketed to startups and small biotech companies with pre-configured workflows for rapid compliance implementation.
This product carries no G2, Capterra, or Gartner Peer Insights listing, so user-reported pain points and common complaints are not documented. Pricing is undisclosed. Implementation complexity for full enterprise deployments and customisation requirements for organisations with unique workflows are not addressed in the vendor's published materials.
Share your experience with PSC ACE anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section